Literature DB >> 27722156

Evaluation of iNOS Expression in Esophageal Cancer Patients.

Romina Barani1, Gholamreza Motalleb2, Hossein Maghsoudi1.   

Abstract

BACKGROUND: Esophageal cancer is a public health concern around the world; this cancer is the sixth leading cause of death of cancer in the world with about 386,000 deaths per year. Its risk factors include environmental factors such as tobacco smoke, gastroesophageal reflux and genetic changes. iNOS is stated by the effect of various inflammatory factors and is thus called inducible NOS. Investigating iNOS expression is a powerful tool for understanding effective molecular parameters at tissue and cellular responses to external factors. In this research work, iNOS expression in patients with esophageal cancer was studied in Iran.
MATERIALS AND METHODS: 15 formalin-fixed and paraffin-embedded (FFPE) esophageal cancer tissue samples and 15 normal FFPE samples were collected from various medical centers (Zabol, Zahedan, Kashan) to measure iNOS expression by real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR). All PCR reactions were conducted by three replicates for iNOS and internal control (β-actin) by 2-ΔΔCT (Livak) method. Differences were measured in target gene expression in patients and control group using the t test. All statistical analyses were done using the SPSS software.
RESULTS: The results showed that there was no significant difference between iNOS expression in the case and control groups (p > 0.05); however, there was an increase in iNOS expression in the case group. On the other hand, there was a significant difference between iNOS expression in males and females in the two groups of healthy subjects and patients, and it was higher in women than in men.
CONCLUSION: Further studies need to be conducted with larger sample sizes and in other populations to validate these findings.

Entities:  

Keywords:  Esophageal cancer; Quantitative real-time reverse transcriptase polymerase chain reaction; iNOS

Year:  2016        PMID: 27722156      PMCID: PMC5040924          DOI: 10.1159/000443976

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  67 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma.

Authors:  Gholamreza Motalleb; Naghmeh Gholipour; Nader Mansour Samaei
Journal:  Med Oncol       Date:  2014-03-22       Impact factor: 3.064

3.  Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells.

Authors:  Jingyuan Chen; Yan Yan; Jingxia Li; Qian Ma; Gary D Stoner; Jianping Ye; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2005-02-17       Impact factor: 4.944

Review 4.  Risk factors for squamous cell carcinoma of the oesophagus.

Authors:  U Ribeiro; M C Posner; A V Safatle-Ribeiro; J C Reynolds
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

5.  Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway.

Authors:  A Musial; N T Eissa
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

6.  P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production.

Authors:  Aleksi Lahti; Hannu Kankaanranta; Eeva Moilanen
Journal:  Eur J Pharmacol       Date:  2002-11-15       Impact factor: 4.432

7.  Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor.

Authors:  Mark M W Chong; Helen E Thomas; Thomas W H Kay
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

8.  Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation.

Authors:  K D Kröncke; V Kolb-Bachofen; B Berschick; V Burkart; H Kolb
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

9.  Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.

Authors:  I B McInnes; B P Leung; M Field; X Q Wei; F P Huang; R D Sturrock; A Kinninmonth; J Weidner; R Mumford; F Y Liew
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  1 in total

1.  Immunosuppressive Phenotype of Esophagus Tumors Stroma.

Authors:  Olga V Kovaleva; Madina A Rashidova; Daria V Samoilova; Polina A Podlesnaya; Valeria V Mochalnikova; Alexei Gratchev
Journal:  Anal Cell Pathol (Amst)       Date:  2020-08-20       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.